June 10, 2021

Humacyte to Participate in Fireside Chat at Cowen 6th Annual FutureHealth Conference

June 08, 2021

Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment

June 04, 2021

Humacyte to Provide Investor Update
on June 7

May 21, 2021

Humacyte Presents Advances in Whole-Lung Engineering

March 5, 2021

Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021

February 17, 2021

Humacyte, a Transformative Biotechnology Platform Company Capable of Manufacturing Universally Implantable Bioengineered Human Tissue at Commercial Scale, Going Public via Merger with Alpha Healthcare Acquisition Corp.

Scroll to Top